Out now:
rdcu.be/evxCvWe've used CoQ10 headgroup intermediates to treat mouse models of a mitochondrial disease and improve the neurological symptoms of a patient with this disease.
Grateful for funding from
@damonrunyon.org , Pershing Square Foundation,
@americancancersoc.bsky.social, NIH!
